Quality of Life and Psychosocial Status of Young-onset Patients With Rectal Cancer
- Disease/Condition
- Rectal Cancer
- Drug/Device/Intervention
- No intervention
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Shandong Provincial Hospital
- Location
- Jinan, China
- Phase
- N/A
- Start date
- Sep 01, 2023
- End date
- Oct 01, 2024
- Enrollment
- 300 participants
Quality-of-life scores,psychosocial status
Colorectal cancer is one of the leading cancers worldwide. Although the majority of CRC cases
 are typically diagnosed in individuals older than 50 years of age, recent international
 studies have highlighted the importance of younger adults ( 50) are gradually increasing.
 Young cancer survivors often have poorer quality of life, disrupted social and sexual health,
 and increased mental health-related risks such as depression and anxiety. Especially for
 patients with rectal cancer, patients may suffer from sexual dysfunction, urinary system
 problems and loss of normal bowel function after radical resection of rectal tumors, and some
 patients may also need to undergo ostomy, which may have adverse effects on the quality of
 life and mental health of patients after surgery. Given that the incidence of colorectal
 cancer in young adults continues to rise worldwide, there is a need to better understand the
 impact of this particular disease on postoperative quality of life in young adults. This
 study intends to retrospectively analyze the clinical characteristics of the patients, and
 further summarize the impact of rectal cancer surgery on the quality of life of patients
 through follow-up.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06216834
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06216834 through Pure Global AI's free database. This phase not specified trial is sponsored by Shandong Provincial Hospital and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.